Today: 13 May 2026
Synopsys Stock Price Slides 5% Friday as Tech Rout Erases Elliott Boost
28 March 2026
1 min read

Synopsys Stock Price Slides 5% Friday as Tech Rout Erases Elliott Boost

NEW YORK, March 28, 2026, 11:09 EDT

Synopsys finished Friday down 5.4% at $380.47, a sharper loss than Cadence Design Systems, which slipped 3.1%. Investors broadly exited growth and software stocks as Wall Street pulled back.

The earlier pop from Elliott Investment Management’s multibillion-dollar stake didn’t last. Synopsys finished roughly 12% under Monday’s $432.48 close—a sharp swing that underscores just how quickly the mood has shifted for high-multiple chip software names.

It was a tough session for the broader market. The Nasdaq slid 2.15% Friday. S&P 500’s software and services index? Back at lows not seen since Nov. 6, 2023. “The overall tone has turned very negative,” said Ken Polcari, chief market strategist at SlateStone Wealth.

Synopsys provides EDA software, shorthand for electronic design automation, which engineers rely on to design and test chips ahead of fabrication. Its main rivals: Cadence and Siemens. Demand here tracks investment in AI and high-performance computing hardware.

The headline-grabbing AI narrative only tells part of the story. Back in February, Synopsys put out a second-quarter revenue forecast between $2.23 billion and $2.28 billion—topping consensus, but management flagged China export curbs and softer demand at a key foundry as trouble spots. “Excluding Ansys, China revenue declined slightly year-over-year, consistent with our outlook,” CFO Shelagh Glaser said. Reuters

Chief Executive Sassine Ghazi earlier this month introduced a set of new tools designed to tackle the increasing complexity of AI chips—marking the first major product launch since the $35 billion Ansys deal. According to Ghazi, engineers “still often work in a siloed way,” a practice he says drives up costs and hampers performance. Reuters

Elliott piled on last week, taking a multibillion-dollar stake in Synopsys and pressing the company to boost both sales and margins, a person familiar with the situation said. Synopsys responded by saying its board and management “regularly engage with our shareholders” and appreciate their feedback. Reuters

Here’s the near-term headache: If oil prices stick at these levels and yields keep climbing, investors may unload more of those expensive software stocks. According to JPMorgan, every persistent 10% jump in oil could trim 15 to 20 basis points off GDP. The bank also warned that if oil hovers around $110 a barrel through the end of 2026, consensus earnings forecasts might get cut by 2% to 5%.

The March U.S. jobs data lands next week, and the Iran conflict continues to produce new developments, with the Nasdaq and Dow both sitting in correction territory. Jim Baird, chief investment officer at Plante Moran Financial Advisors, said a breakthrough with Iran could help calm investors, but a prolonged standoff would likely weigh on sentiment.

Next up for Synopsys: can AI momentum, the Ansys deal, and Elliott’s push offset headwinds from China, acquisition debt, and a market that’s trimmed what it will shell out for growth stocks lately? As of Friday’s close, investors aren’t convinced.

Stock Market Today

  • Analog Devices (ADI) Stock Valuation Assessment Amid Strong Price Gains
    May 13, 2026, 2:53 PM EDT. Analog Devices (ADI) stock has surged nearly 20% in the past 30 days and delivered an 87.95% total shareholder return over one year, drawing investor attention. The stock trades at $419.65, about 6.8% above its modeled fair value of $392.94, indicating potential overvaluation. Drivers include growth from robotics and automation expanding ADI's addressable market and boosting revenue. However, risks remain from increased competition in China and rising manufacturing and R&D costs that could pressure margins. Investors should weigh ADI's growth potential against these challenges when considering inclusion in portfolios.

Latest articles

Palantir Stock Slides as Zelenskiy Meeting Puts War-AI Bet in Focus

Palantir Stock Slides as Zelenskiy Meeting Puts War-AI Bet in Focus

13 May 2026
Palantir shares fell 4.4% to $129.97 Wednesday as CEO Alex Karp met President Volodymyr Zelenskiy in Kyiv to discuss expanding AI use in Ukraine’s war effort. Kyiv’s Brave1 Dataroom project, launched with Palantir, is training AI models to intercept Russian drones. Russia fired at least 800 drones at Ukraine on Wednesday, killing six. Palantir’s U.S. government and commercial revenue surged in the first quarter.
Why Grab Holdings Stock Is Back Under Pressure After a Big Q1 Beat

Why Grab Holdings Stock Is Back Under Pressure After a Big Q1 Beat

13 May 2026
Grab shares fell 1.1% to $3.60 in New York after first-quarter revenue beat estimates, rising 24% to $955 million. Profit jumped to $120 million from $10 million a year earlier. Investors weighed strong results against Indonesia’s new 8% ride-hailing commission cap. Grab kept its 2026 revenue and adjusted EBITDA outlook unchanged.
SoFi Bought a Key IPO Access Tool. The Stock Is Still Telling a More Cautious Story

SoFi Bought a Key IPO Access Tool. The Stock Is Still Telling a More Cautious Story

13 May 2026
SoFi acquired PrimaryBid’s technology to expand IPO access for retail investors, confirmed by both companies. SoFi shares fell 2.9% to $15.44 after Truist cut its price target, citing concerns over loan and technology platforms. The acquisition follows a drop in technology-platform accounts and comes as SoFi reported strong first-quarter revenue and member growth. Terms of the deal were not disclosed.

Popular

Nebius Stock’s Pre-Market Bounce Puts the AI Factory Trade Back on Trial

Nebius Stock’s Pre-Market Bounce Puts the AI Factory Trade Back on Trial

13 May 2026
Nebius Group shares rose 3.53% to $185.42 in early extended trading after a 3.76% drop Tuesday, ahead of its Q1 earnings release. The company broke ground on a gigawatt-scale AI factory in Missouri and announced a technology deal with Clarifai’s founder and team. NBIS is up 32.79% in the past month and 454.18% over the past year. Investors are weighing rapid expansion against ongoing losses and heavy capital spending.
American Airlines (AAL) Stock Price Falls Nearly 4% as Oil Spike Puts 2026 Outlook Under Pressure
Previous Story

American Airlines (AAL) Stock Price Falls Nearly 4% as Oil Spike Puts 2026 Outlook Under Pressure

Vertex Pharmaceuticals Stock Falls 4.6% After FDA Label Warning Hits Alyftrek, Trikafta
Next Story

Vertex Pharmaceuticals Stock Falls 4.6% After FDA Label Warning Hits Alyftrek, Trikafta

Go toTop